• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Trajectory of Heart Failure Treatment Strategies

Opinion
Video

Experts highlight the future of heart failure management.

This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD.

When asked about the future of heart failure management, Desai says he is excited about better phenotyping beyond ejection fraction to personalize care. Groves notes this complexity reinforces the need for collaborative, integrative care models. Albert looks forward to disruptive innovations such as devices putting control in patients’ hands, such as glucose monitors for diabetes. Axsom envisions remote monitoring technology empowering self-management. Wright would like research on biomarkers predicting heart failure progression rates to guide treatment intensity. Groves stresses addressing social determinants such as nutrition that influence life outside healthcare visits. Asking where patients shop for food provides insights. In summary, the future of heart failure care involves better phenotyping, disruptive technologies, remote monitoring, risk stratification tools, and addressing social needs, all aimed at optimizing outcomes through individualized, patient-centered care.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Stephanie L. Graff, MD, an expert on breast cancer
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.